B · Normal
On September 28, the U.S. Food and Drug Administration (FDA) approved AbbVie’s JUVMO™ (tavapadon) for the treatment of Parkinson’s disease.
Related telegraphs
On September 29th, Boeing's decline expanded to 6.6%, its worst intraday perform
09-29 02:25
On September 29th, the New York City Speaker said that OpenAI, Anthropic and Goo
09-29 01:11
[The Nasdaq China Golden Dragon Index’s increase expanded to 1.5%] On September
09-29 00:33
On September 28th, SpaceX announced that the starship is on its way to re-enter
09-28 23:16
[While the overall U.S. stock market fell, most Chinese concept stocks rose, Net
09-28 23:09
On September 28th, SpaceX announced that it had established communication connec
09-28 23:02
Comments